Markus P. R.
- Country
- Austria
- Department
- Department of Internal Medicine
Research Overview
- Evaluation of Safety, Engraftment, and Initial Clinical Activity of MB310 in Patients with Active Mild to Moderate Ulcerative Colitis: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
Data & Insights
Has run more than one trial at 237 of 516 partner sites.
Specializations
Liver Disease Expertise
This investigator specializes in treating advanced hepatocellular carcinoma and associated liver conditions. Their research encompasses both early-stage interventions and treatments for advanced disease states.
- Intermediate and advanced-stage HCC management
- Neoadjuvant immunotherapy approaches
- Post-surgical recurrence prevention
Their work includes evaluating novel therapeutic combinations and immunotherapy-based treatments for liver cancer.
Gastroenterological Disorders
The investigator focuses on innovative treatments for chronic digestive system conditions, including Crohn's Disease and Ulcerative Colitis.
- Inflammatory bowel disease management
- Celiac disease treatment approaches
- Gastrointestinal therapeutic innovations
Their research extends to evaluating new therapeutic agents for various gastrointestinal conditions.
Metabolic and Genetic Conditions
The investigator studies treatments for genetic and metabolic disorders, with particular emphasis on Alpha-1 Antitrypsin Deficiency and Non-Alcoholic Steatohepatitis.
- Liver fibrosis treatment
- NASH progression management
- Genetic liver disease therapies
Their work includes evaluation of novel therapeutic approaches for rare genetic conditions affecting the liver.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.